Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by ChiChi3on Feb 11, 2008 11:50am
209 Views
Post# 14349912

RE: A show of hands

RE: A show of handsMy guess is that ISA will want to hammer out a deal with Roche while they are strong financially. I'm thinking they release the data results publicly before Roche has time to make up its mind so that the stock price spikes (hopefully). They will then do a financing to raise enough cash to keep going and negotiate with other players just in case Roche opts out. Otherwise I think Roche opts out, the share price spikes down and Roche buys ISA at a price even cheaper than it is today. If ISA can show they are strong, Roche will opt in. So, to make a long story short: 1.) IN 2.) YES 3.) YES 4.) $6 Chi
Bullboard Posts